Silver Creek Pharmaceuticals Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Silver Creek Pharmaceuticals is a clinical-stage biotechnology company based in South San Francisco, California. It focuses on developing therapies designed to repair damaged tissues, with the aim of offering treatments for conditions that require tissue healing. In 2025, the company announced positive Phase II results for its candidate scp776 in acute ischemic stroke, presented at the World Stroke Congress in Barcelona. The company positions itself as a developer of growth factor-based therapeutics within the biotechnology research industry.